Myocardial calcification in a patient with B-lymphoblastic leukemia accompanied by tumor lysis syndrome. 2019

Genki Usui, and Hirotsugu Hashimoto, and Yusuke Uchibori, and Kensuke Usuki, and Hajime Horiuchi, and Teppei Morikawa
Department of Diagnostic Pathology, NTT Medical Center Tokyo, Tokyo, Japan.

Myocardial calcification, a rare disease that leads to chronic or acute heart failure and with a poor prognosis, occurs in patients with abnormal calcium-phosphorus metabolism. The association between myocardial calcification and tumor lysis syndrome has not been reported to date. A 50-year-old man with hyperthermia and general malaise presented to our hospital and was clinically diagnosed with B-lymphoblastic leukemia (B-ALL) and febrile neutropenia accompanied by septic shock. Prednisolone was administered for tumor reduction. Two to three hours later, electrocardiography demonstrated ST elevation in V4-6, and blood tests showed elevated levels of cardiac enzymes. Transthoracic echocardiogram revealed diffuse severe hypokinesis with decreased left ventricular ejection fraction. Additionally, blood tests showed that serum phosphorus level increased to 8.0 mg/dl, which was likely due to tumor lysis syndrome. Circulatory and respiratory failure due to left heart failure progressed, and he died 3 days after administration of prednisolone. Pathological autopsy revealed diffuse proliferation of atypical B-lymphoblasts in the bone marrow, which led to the pathological diagnosis of B-ALL, accompanied by necrosis. On the cut surface of the heart, the left ventricle was dilated, and patchy yellowish-brown areas were present in the epicardial-side of the myocardium and spread through the circumferential wall of the left ventricle and interventricular septum. Microscopically, myocardial fibers were granularly basophilic in that area and were revealed as calcium deposits by Von Kossa staining. He was diagnosed with myocardial calcification. The drastic increase in the serum phosphorus level caused by tumor lysis syndrome seemed to be associated with myocardial calcification.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009202 Cardiomyopathies A group of diseases in which the dominant feature is the involvement of the CARDIAC MUSCLE itself. Cardiomyopathies are classified according to their predominant pathophysiological features (DILATED CARDIOMYOPATHY; HYPERTROPHIC CARDIOMYOPATHY; RESTRICTIVE CARDIOMYOPATHY) or their etiological/pathological factors (CARDIOMYOPATHY, ALCOHOLIC; ENDOCARDIAL FIBROELASTOSIS). Myocardial Disease,Myocardial Diseases,Myocardial Diseases, Primary,Myocardial Diseases, Secondary,Myocardiopathies,Primary Myocardial Disease,Cardiomyopathies, Primary,Cardiomyopathies, Secondary,Primary Myocardial Diseases,Secondary Myocardial Diseases,Cardiomyopathy,Cardiomyopathy, Primary,Cardiomyopathy, Secondary,Disease, Myocardial,Disease, Primary Myocardial,Disease, Secondary Myocardial,Diseases, Myocardial,Diseases, Primary Myocardial,Diseases, Secondary Myocardial,Myocardial Disease, Primary,Myocardial Disease, Secondary,Myocardiopathy,Primary Cardiomyopathies,Primary Cardiomyopathy,Secondary Cardiomyopathies,Secondary Cardiomyopathy,Secondary Myocardial Disease
D009206 Myocardium The muscle tissue of the HEART. It is composed of striated, involuntary muscle cells (MYOCYTES, CARDIAC) connected to form the contractile pump to generate blood flow. Muscle, Cardiac,Muscle, Heart,Cardiac Muscle,Myocardia,Cardiac Muscles,Heart Muscle,Heart Muscles,Muscles, Cardiac,Muscles, Heart
D010758 Phosphorus A non-metal element that has the atomic symbol P, atomic number 15, and atomic weight 31. It is an essential element that takes part in a broad variety of biochemical reactions. Black Phosphorus,Phosphorus-31,Red Phosphorus,White Phosphorus,Yellow Phosphorus,Phosphorus 31,Phosphorus, Black,Phosphorus, Red,Phosphorus, White,Phosphorus, Yellow
D011239 Prednisolone A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states. Di-Adreson-F,Predate,Predonine,Di Adreson F,DiAdresonF
D002114 Calcinosis Pathologic deposition of calcium salts in tissues. Calcification, Pathologic,Calcinosis, Tumoral,Microcalcification,Microcalcinosis,Pathologic Calcification,Calcinoses,Calcinoses, Tumoral,Microcalcifications,Microcalcinoses,Tumoral Calcinoses,Tumoral Calcinosis
D002423 Cause of Death Factors which produce cessation of all vital bodily functions. They can be analyzed from an epidemiologic viewpoint. Causes of Death,Death Cause,Death Causes
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy

Related Publications

Genki Usui, and Hirotsugu Hashimoto, and Yusuke Uchibori, and Kensuke Usuki, and Hajime Horiuchi, and Teppei Morikawa
December 2012, Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners,
Genki Usui, and Hirotsugu Hashimoto, and Yusuke Uchibori, and Kensuke Usuki, and Hajime Horiuchi, and Teppei Morikawa
December 2023, Pediatric blood & cancer,
Genki Usui, and Hirotsugu Hashimoto, and Yusuke Uchibori, and Kensuke Usuki, and Hajime Horiuchi, and Teppei Morikawa
September 2005, The Journal of the Association of Physicians of India,
Genki Usui, and Hirotsugu Hashimoto, and Yusuke Uchibori, and Kensuke Usuki, and Hajime Horiuchi, and Teppei Morikawa
April 2016, Ginecologia y obstetricia de Mexico,
Genki Usui, and Hirotsugu Hashimoto, and Yusuke Uchibori, and Kensuke Usuki, and Hajime Horiuchi, and Teppei Morikawa
September 1992, American journal of hematology,
Genki Usui, and Hirotsugu Hashimoto, and Yusuke Uchibori, and Kensuke Usuki, and Hajime Horiuchi, and Teppei Morikawa
May 2010, Pediatric blood & cancer,
Genki Usui, and Hirotsugu Hashimoto, and Yusuke Uchibori, and Kensuke Usuki, and Hajime Horiuchi, and Teppei Morikawa
November 1987, Deutsche medizinische Wochenschrift (1946),
Genki Usui, and Hirotsugu Hashimoto, and Yusuke Uchibori, and Kensuke Usuki, and Hajime Horiuchi, and Teppei Morikawa
June 1999, Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi,
Genki Usui, and Hirotsugu Hashimoto, and Yusuke Uchibori, and Kensuke Usuki, and Hajime Horiuchi, and Teppei Morikawa
February 2015, Pediatric reports,
Genki Usui, and Hirotsugu Hashimoto, and Yusuke Uchibori, and Kensuke Usuki, and Hajime Horiuchi, and Teppei Morikawa
March 1999, American journal of hematology,
Copied contents to your clipboard!